Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Ronald Reagan, Alzheimer's Disease and Cogniceuticals | Main | Improving Software Productivity via Neurofeedback (A proposal) »

June 6, 2004

BIO 2004 Conference June 6-9, San Francisco

Email This Entry

Posted by Zack Lynch

The BIO 2004 Annual International Convention that begins today in San Francisco is the world's largest biotechnology gathering. BIO 2004 runs June 6-9 at the Moscone Center and offers 23 tracks of programming, including sessions on policy, finance, business development, science and regulatory affairs. The convention also features forums on bioethics, business development and global opportunities with over 440,000 square feet of exhibit space. I'll be covering the conference with a heavy focus on neurotechnology over the next few days.

Comments (0) + TrackBacks (0) | Category: SF Focus



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives